Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | PPM1B | O75688 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27630475 | 0.89 | PPM1B (0.44) | CHRM2CHRM4CHRM3EPHX1PPM1B | |
| SCHEMBL13658097 | 0.87 | PPM1B (0.44) | CHRM2CHRM4CHRM3EPHX1PPM1B | |
| SCHEMBL1297572 | 0.87 | CHRM2 (0.48) | CHRM2CHRM4CHRM3PPM1BPTPN1 | |
| SCHEMBL25600204 | 0.85 | CHRM2 (0.52) | CHRM2CHRM4CHRM3EPHX1PPM1B | |
| SCHEMBL14087020 | 0.85 | CHRM2 (0.52) | CHRM2CHRM4CHRM3EPHX1PPM1B | |
| SCHEMBL5523171 | 0.85 | CHRM2 (0.52) | CHRM2CHRM4CHRM3EPHX1PPM1B | |
| SCHEMBL8349523 | 0.85 | CHRM2 (0.52) | CHRM2CHRM4CHRM3EPHX1PPM1B | |
| SCHEMBL1297620 | 0.82 | PPM1B (0.48) | CHRM2CHRM4CHRM3PPM1BPTPN1 | |
| SCHEMBL265337 | 0.81 | EPHX1 (0.56) | CHRM2CHRM4CHRM3EPHX1SLC6A2 | |
| SCHEMBL13813780 | 0.81 | EPHX1 (0.56) | CHRM2CHRM4CHRM3EPHX1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066515-A1 | METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, METHOD FOR PRODUCING CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-02-27 | — | — | US | disclosed |
| US-12234312-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-02-25 | — | — | US | disclosed |
| US-12173107-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-12-24 | — | — | US | disclosed |
| CN-119161509-A | Solid catalyst component for olefin polymerization | 住友化学株式会社 | 2024-12-20 | — | — | CN | disclosed |
| CN-114057913-B | Solid catalyst component for olefin polymerization | 住友化学株式会社 | 2024-10-11 | — | — | CN | disclosed |
| US-12037441-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-16 | — | — | US | disclosed |
| US-20240076423-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-03-07 | — | — | US | disclosed |
| CN-113105690-B | Heterophasic propylene polymer material and use thereof | 住友化学株式会社 | 2024-03-01 | — | — | CN | disclosed |
| US-11840595-B2 | Solid catalyst component for olefin polymerization | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-12-12 | — | — | US | disclosed |
| US-20230303730-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-28 | — | — | US | disclosed |
| EP-3744784-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND METHOD OF PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-12-02 | — | — | EP | disclosed |
| CN-112011129-A | Thermoplastic elastomer composition and method for producing same | 住友化学株式会社 | 2020-12-01 | — | — | CN | disclosed |
| US-10800911-B2 | Heterophasic propylene polymerization material | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-10-13 | — | — | US | disclosed |
| WO-2019176913-A1 | HETEROPHASIC PROPYLENE POLYMERIZATION MATERIAL | 住友化学株式会社 | 2019-09-19 | — | — | WO | disclosed |
| US-20190161605-A1 | HETEROPHASIC PROPYLENE POLYMERIZATION MATERIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-05-30 | — | — | US | disclosed |
| WO-2017024318-A1 | TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-02-09 | — | — | WO | disclosed |
| US-7282601-B2 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-10-16 | — | — | US | disclosed |
| US-7271282-B1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-09-18 | — | — | US | disclosed |
| US-20050038283-A1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | NEW JAPAN CHEMICAL, CO., LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1227078-A1 | DICARBOXYLIC DIESTER, PROCESS FOR PRODUCING THE SAME, AND REFRIGERATING MACHINE LUBRICATING OIL COMPRISING THE ESTER | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2002-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038283-A1 | Dicarboxylic diester, process for producing the same, and refrigerating machine lubricating oil comprising the ester | SCO2, PDHX, DECR2 | CHRM2 456/4885CHRM4 268/4885CHRM3 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.